AKUMS
Invest with MTF
Invest Now
Invest in Akums Drugs & Pharmaceuticals with 3.26X leverage
Akums Drugs & Pharmaceuticals live price: ₹464.45. It opened at ₹468 vs previous close ₹470; intraday high/low: ₹481/₹462. The 50 & 200 DMA stand at ₹465.47/₹491.64.
Akums Drugs & Pharmaceuticals Performance
- Low
- ₹462
- High
- ₹481
- 52 Week Low
- ₹405
- 52 Week High
- ₹623
- Open Price₹468
- Previous Close₹470
- Volume120,166
- 50 DMA₹465.47
- 100 DMA₹462.34
- 200 DMA₹491.64
Investment Returns
- Over 1 Month + 3.01%
- Over 3 Month + 9.9%
- Over 6 Month -1.15%
- Over 1 Year -8.88%
Smart Investing Starts Here Start SIP with Akums Drugs & Pharmaceuticals for Steady Growth!
Akums Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 23
- PEG Ratio
- 0.2
- Market Cap Cr
- 7,310
- P/B Ratio
- 2.3
- Average True Range
- 18.06
- EPS
- 20.62
- Dividend Yield
- 0
- MACD Signal
- 9.18
- RSI
- 48.06
- MFI
- 56.16
Akums Drugs & Pharmaceuticals Financials
Akums Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹464.45
-5.85
(-1.24%)
- Bearish Moving Average 12
- Bullish Moving Average 4
- 20 Day
- ₹479.41
- 50 Day
- ₹465.47
- 100 Day
- ₹462.34
- 200 Day
- ₹491.64
Resistance and Support
478.73
- R3 519.37
- R2 508.63
- R1 489.47
- S1 459.57
- S2 448.83
- S3 429.67
Akums Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-13 | Quarterly Results | |
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-06 | Quarterly Results |
Akums Drugs & Pharmaceuticals F&O
About Akums Drugs & Pharmaceuticals
- NSE Symbol
- AKUMS
- BSE Symbol
- 544222
- Managing Director
- Mr. Sanjeev Jain
- ISIN
- INE09XN01023
Similar Stocks to Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals FAQs
Akums Drugs & Pharmaceuticals share price is ₹464 As on 16 March, 2026 | 14:49
The Market Cap of Akums Drugs & Pharmaceuticals is ₹7310.2 Cr As on 16 March, 2026 | 14:49
The P/E ratio of Akums Drugs & Pharmaceuticals is 23 As on 16 March, 2026 | 14:49
The PB ratio of Akums Drugs & Pharmaceuticals is 2.3 As on 16 March, 2026 | 14:49
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.